home / stock / mcrb / mcrb quote
Last: | $0.7295 |
---|---|
Change Percent: | 1.32% |
Open: | $0.75 |
Close: | $0.7295 |
High: | $0.785799 |
Low: | $0.6955 |
Volume: | 5,807,574 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.7295 | $0.75 | $0.7295 | $0.785799 | $0.6955 | 5,807,574 | 04-24-2024 |
$0.76 | $0.639 | $0.76 | $0.8029 | $0.6288 | 11,835,379 | 04-23-2024 |
$0.6246 | $0.6 | $0.6246 | $0.635 | $0.581 | 4,223,862 | 04-22-2024 |
$0.5599 | $0.58 | $0.5599 | $0.606 | $0.54 | 3,748,612 | 04-19-2024 |
$0.5842 | $0.6273 | $0.5842 | $0.6326 | $0.5805 | 3,788,552 | 04-18-2024 |
$0.6273 | $0.6526 | $0.6273 | $0.655 | $0.60201 | 4,825,050 | 04-17-2024 |
$0.6361 | $0.6159 | $0.6361 | $0.6599 | $0.6071 | 4,161,240 | 04-16-2024 |
$0.6179 | $0.64 | $0.6179 | $0.6536 | $0.6114 | 3,852,426 | 04-15-2024 |
$0.6547 | $0.7 | $0.6547 | $0.7005 | $0.6308 | 4,133,511 | 04-12-2024 |
$0.6822 | $0.6945 | $0.6822 | $0.7 | $0.6605 | 4,662,564 | 04-11-2024 |
$0.6894 | $0.6946 | $0.6894 | $0.6983 | $0.6601 | 4,964,652 | 04-10-2024 |
$0.7094 | $0.72 | $0.7094 | $0.7478 | $0.6866 | 6,990,342 | 04-09-2024 |
$0.7324 | $0.751 | $0.7324 | $0.7539 | $0.725 | 2,893,478 | 04-08-2024 |
$0.7626 | $0.77 | $0.7626 | $0.7797 | $0.7314 | 3,322,698 | 04-05-2024 |
$0.7551 | $0.7327 | $0.7551 | $0.7905 | $0.715 | 4,329,020 | 04-04-2024 |
$0.7256 | $0.7613 | $0.7256 | $0.77 | $0.7103 | 6,112,178 | 04-03-2024 |
$0.7628 | $0.7785 | $0.7628 | $0.7785 | $0.75 | 2,002,488 | 04-02-2024 |
$0.767 | $0.78 | $0.767 | $0.7986 | $0.752 | 3,245,530 | 04-01-2024 |
$0.7741 | $0.787 | $0.7741 | $0.7982 | $0.7616 | 3,020,812 | 03-29-2024 |
$0.7741 | $0.787 | $0.7741 | $0.7982 | $0.7616 | 3,020,812 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Seres Therapeutics Inc. Company Name:
MCRB Stock Symbol:
NASDAQ Market:
Seres Therapeutics Inc. Website:
Clinical data readout expected end of Q3 2024 SER-155 and other Seres microbiome therapeutic candidates have potential to expand microbiome therapeutic franchise into additional medically vulnerable patient populations Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiom...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
VOWST net sales of $10.4 million for the fourth quarter of 2023 and $19.6 million since launch in June through year-end 2023 Significant adoption of VOWST since launch in June 2023 through year-end 2023 with 2,833 patient enrollment forms received and 2,015 new patient starts ...